Quantum Computing Earnings Call Transcripts
Fiscal Year 2025
-
2025 saw major strategic progress, including a key acquisition, new product launches, and a shift to commercial manufacturing. Revenue and financial position improved significantly, with strong capital raised and a clear roadmap for scaling in 2026.
-
Q3 2025 saw strong revenue growth, a return to profitability, and a major boost in capital, positioning the company to scale quantum and photonic manufacturing. Key commercial wins, industry partnerships, and a robust balance sheet support an ambitious three-year roadmap.
-
Q2 2025 saw increased commercial traction, major government contracts, and the launch of a new photonic chip foundry. Despite a higher net loss due to non-cash items, the balance sheet was strengthened by a $200 million financing, positioning the company for future growth.
-
Expansion into North America is the top priority through 2027, with a focus on flagship bitters and non-alcoholic spirits. Financials show improving margins and reduced losses, with break-even targeted at $1.4 million in high-margin sales. Leadership transition and increased marketing are planned for 2024-2025.
-
First quarter 2025 saw revenue growth, a major foundry launch, and strengthened finances, with net income boosted by a non-cash gain. New customer wins and research partnerships signal expanding market traction and a positive outlook for accelerated growth in 2026.
Fiscal Year 2024
-
Q4 2024 saw major operational and financial progress, including improved gross margins, expanded NASA contracts, and a strengthened balance sheet with over $170 million in new capital. The company is set to begin foundry production in Q2 2025 and is well positioned for revenue growth and industry leadership.
-
Q3 2024 saw revenue double year-over-year, driven by new contracts and progress on the Arizona TFLN foundry, though gross margin declined due to project mix. Cost containment improved net loss, and significant capital was raised to support growth and upcoming foundry operations.